A carregar...

Tumor priming enhances siRNA delivery and transfection in intraperitoneal tumors

Cancers originating from digestive system account for 290,000 or ~20% of all new cancer cases annually in the US. We previously developed paclitaxel-loaded tumor-penetrating microparticles (TPM) for intraperitoneal (IP) treatment of peritoneal tumors [1–3]. TPM is undergoing NIH-supported IND-enabli...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wang, Jie, Lu, Ze, Yeung, Bertrand Z., Wientjes, M. Guillaume, Cole, David J., Au, Jessie L.-S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3994124/
https://ncbi.nlm.nih.gov/pubmed/24462901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2014.01.012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!